. Unaids, Report on the global AIDS epidemic. Geneva Available at: http://www.unaids.org/en/HIV_data HIV antiretroviral drug resistance in Africa, Nkengasong JN AIDS Rev, vol.6, issue.2, pp.4-12, 2004.

T. Toni, B. Masquelier, and D. Bonard, Primary HIV-1 drug resistance in Abidjan (C??te d'Ivoire): a genotypic and phenotypic study, AIDS, vol.16, issue.3, pp.488-491, 2002.
DOI : 10.1097/00002030-200202150-00024

L. Vergne, C. Kane, and C. Laurent, Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy, AIDS, vol.17, issue.3, pp.31-38, 2003.
DOI : 10.1097/00002030-200317003-00005

M. Bellocchi, F. Forbici, and L. Palombi, Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme, Journal of Medical Virology, vol.183, issue.4, pp.452-458, 2005.
DOI : 10.1002/jmv.20382

C. Adje, R. Cheingsong, and T. Roels, High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, C??te d'Ivoire, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.26, issue.5, pp.501-506, 2001.
DOI : 10.1097/00126334-200104150-00018

L. Vergne, G. Malonga-mouellet, and I. Mistoul, Resistance to Antiretroviral Treatment in Gabon: Need for Implementation of Guidelines on Antiretroviral Therapy Use and HIV-1 Drug Resistance Monitoring in Developing Countries, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.29, issue.2, pp.165-168, 2002.
DOI : 10.1097/00042560-200202010-00009

P. Weidle, S. Malamba, and R. Mwebaze, Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance, The Lancet, vol.360, issue.9326, pp.34-40, 2002.
DOI : 10.1016/S0140-6736(02)09330-3

C. Seyler, X. Anglaret, and N. Dakoury-dogbo, Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Antivir Ther, vol.8, pp.385-393, 2003.

X. Anglaret, E. Messou, and T. Ouassa, Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, C??te d'Ivoire, AIDS, vol.17, issue.4, pp.575-584, 2003.
DOI : 10.1097/00002030-200303070-00013

X. Anglaret, N. Dakoury-dogbo, and D. Bonard, Causes and empirical treatment of fever in HIV-infected adult outpatients, Abidjan, C??te d'Ivoire, AIDS, vol.16, issue.6, pp.909-918, 2002.
DOI : 10.1097/00002030-200204120-00011

X. Anglaret, S. Toure, and G. Gourvellec, Impact of Vital Status Investigation Procedures on Estimates of Survival in Cohorts of HIV-Infected Patients From Sub-Saharan Africa, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.3, pp.320-323, 2004.
DOI : 10.1097/00126334-200403010-00015

F. Rouet, D. Ekouevi, and M. Chaix, Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2717, 2005.
DOI : 10.1128/JCM.43.6.2709-2717.2005

E. Bile, C. Adje-toure, and M. Borget, Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, C??te d???Ivoire, Journal of Clinical Virology, vol.32, issue.1, pp.60-66, 2005.
DOI : 10.1016/j.jcv.2004.07.008

V. Johnson, F. Brun-vezinet, and B. Clotet, Update of the drug resistance mutations in HIV-1: Fall, Top HIV Med, vol.14, pp.125-130, 2006.

N. Richard, M. Juntilla, and A. Abraha, High Prevalence of Antiretroviral Resistance in Treated Ugandans Infected with Non-subtype B Human Immunodeficiency Virus Type 1, AIDS Research and Human Retroviruses, vol.20, issue.4, pp.355-364, 2004.
DOI : 10.1089/088922204323048104

C. Laurent, C. Kouanfack, and L. Vergne, Antiretroviral Drug Resistance and Routine Therapy, Cameroon, Emerging Infectious Diseases, vol.12, issue.6, pp.1001-1004, 2006.
DOI : 10.3201/eid1206.050860
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298273

L. Ferradini, A. Jeannin, and L. Pinoges, Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet, vol.367, issue.9519, pp.1335-1342, 2006.
DOI : 10.1016/S0140-6736(06)68580-2

M. Zaccarelli, V. Tozzi, and P. Lorenzini, Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients, AIDS, vol.19, issue.10, pp.1081-1089, 2005.
DOI : 10.1097/01.aids.0000174455.01369.ad

R. Hogg, D. Bangsberg, and V. Lima, Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART, PLoS Medicine, vol.18, issue.9, p.3, 2006.
DOI : 10.1371/journal.pmed.0030356.t004

G. Lucas, J. Gallant, and R. Moore, Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing, AIDS, vol.18, issue.11, pp.1539-1548, 2004.
DOI : 10.1097/01.aids.0000131339.68666.1a

N. Machouf, R. Thomas, and V. Nguyen, Effects of drug resistance on viral load in patients failing antiretroviral therapy, Journal of Medical Virology, vol.19, issue.5, pp.608-613, 2006.
DOI : 10.1002/jmv.20582

S. Deeks, J. Barbour, J. Martin, M. Swanson, and R. Grant, T Cell Response after Virologic Failure of Protease Inhibitor???Based Regimens in Patients with Human Immunodeficiency Virus Infection, The Journal of Infectious Diseases, vol.181, issue.3, pp.946-953, 2000.
DOI : 10.1086/315334

A. Cozzi-lepri, A. Phillips, and V. Miller, Changes in viral load in people with virological failure who remain on the same HAART regimen, Antivir Ther, vol.8, pp.127-136, 2003.

J. Martinez-picado, A. Savara, L. Sutton, D. Aquila, and R. , Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1, J Virol, vol.73, pp.3744-3752, 1999.

S. Deeks, T. Wrin, and T. Liegler, Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia, New England Journal of Medicine, vol.344, issue.7, pp.472-480, 2001.
DOI : 10.1056/NEJM200102153440702

B. Ledergerber, J. Lundgren, and A. Walker, Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes, The Lancet, vol.364, issue.9428, pp.51-62, 2004.
DOI : 10.1016/S0140-6736(04)16589-6

R. Kantor, R. Shafer, and S. Follansbee, Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy, AIDS, vol.18, issue.11, pp.1503-1511, 2004.
DOI : 10.1097/01.aids.0000131358.29586.6b

M. Goetz, M. Ferguson, and X. Han, Evolution of HIV Resistance Mutations in Patients Maintained on a Stable Treatment Regimen After Virologic Failure, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.PAP, issue.15, pp.541-550, 2006.
DOI : 10.1097/01.qai.0000245882.28391.0c

S. Goldie, Y. Yazdanpanah, and E. Losina, Cost-Effectiveness of HIV Treatment in Resource-Poor Settings ??? The Case of C??te d'Ivoire, New England Journal of Medicine, vol.355, issue.11, pp.1141-53, 2006.
DOI : 10.1056/NEJMsa060247